Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanxi Dayu Biological Functions Co Buyback Yield % Chart
BJSE:920970 vs VRTX, REGN, MRNA: Buyback Yield % Comparison
For the Biotechnology subindustry, Shanxi Dayu Biological Functions Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanxi Dayu Biological Functions Co Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanxi Dayu Biological Functions Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Shanxi Dayu Biological Functions Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanxi Dayu Biological Functions Co (BJSE:920970) has a Buyback Yield % of 0.00 as of Sep. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Shanxi Dayu Biological Functions Co and its competitors. According to the industry distribution chart, Shanxi Dayu Biological Functions Co ranks #999999 out of 703 companies in the Biotechnology industry.
Is Shanxi Dayu Biological Functions Co's Buyback Yield % too high?
Shanxi Dayu Biological Functions Co's current Buyback Yield % is 0.00. Based on the distribution chart, Shanxi Dayu Biological Functions Co ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shanxi Dayu Biological Functions Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanxi Dayu Biological Functions Co's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanxi Dayu Biological Functions Co ranks #999999 out of 703 companies for Buyback Yield %. This places Shanxi Dayu Biological Functions Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Shanxi Dayu Biological Functions Co and its competitors. Shanxi Dayu Biological Functions Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanxi Dayu Biological Functions Co stock overvalued right now?
Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co (BJSE:920970) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.25, compared to a current price of ¥6.81 — trading 6.1% below its estimated fair value. The current Buyback Yield % is 0.00. Shanxi Dayu Biological Functions Co's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Shanxi Dayu Biological Functions Co (BJSE:920970), the current Buyback Yield % is 0.00 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanxi Dayu Biological Functions Co (BJSE:920970) Overvalued in 2026?
Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co stock appears to be undervalued.
The current stock price of ¥6.81 is trading 6.1% below its estimated GF Value™ of ¥7.25.
GuruFocus considers Shanxi Dayu Biological Functions Co to be Fairly Valued.
Key valuation signals for BJSE:920970:
Buyback Yield %: 0.00
GF Value™: ¥7.25 vs. price of ¥6.81 (6.1% below fair value)
No single metric tells the full story. See the BJSE:920970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanxi Dayu Biological Functions Co Ltd engages in the research and development of bioengineering technology and product application. Its main products are probiotics, enzyme preparations, fermented traditional Chinese medicine, biological preparations, and veterinary preparations.
63GF Score
Get the complete analysis for BJSE:920970
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920970 has been successfully added to your 
